Xenon Pharmaceuticals Inc.

  • Date: 2016-03-08

Download Original Document

FORM 13-502F1 CLASS 1 AND CLASS 3B REPORTING ISSUERS – PARTICIPATION FEE MANAGEMENT CERTIFICATION Ian Mortimer I, _______________________, an officer of the reporting issuer noted below have examined this Form 13-502F1 (the Form) being submitted hereunder to the Ontario Securities Commission and certify that to my knowledge, having exercised reasonable diligence, the information provided in the Form is complete and accurate. Ian Mortimer March 8, 2016 (s)________________________________ __________________________ Ian Mortimer Name: Date: Title: Chief Financial Officer & Chief Operating Officer

Reporting Issuer Name:

Xenon Pharmaceuticals Inc.

End date of previous financial year:

December 31, 2015

Type of Reporting Issuer:

✔ Class 1 reporting issuer …

Highest Trading Marketplace:

NASDAQ

… Class 3B reporting issuer

(refer to the definition of “highest trading marketplace” under OSC Rule 13-502 Fees)

Market value of listed or quoted equity securities: (in Canadian Dollars - refer to section 7.1 of OSC Rule 13-502 Fees)

Equity Symbol XENE _________________________ st

1 Specified Trading Period (dd/mm/yy) (refer to the definition of “specified trading period” under OSC Rule 13-502 Fees)

01/01/15 31/03/15 _________________ to _________________

Closing price of the security in the class or series on the last trading day of the specified trading period in which such security was listed or quoted on the highest trading marketplace

16.865 $________________________ (i)

Number of securities in the class or series of such security outstanding at the end of the last trading day of the specified trading period

14,222,275 _________________________ (ii)

Market value of class or series

(i) x (ii)

239,858,667.88 $_________________________ (A)

2nd Specified Trading Period (dd/mm/yy) (refer to the definition of “specified trading period” under OSC Rule 13-502 Fees)

01/04/15 30/06/15 _________________ to _________________

Closing price of the security in the class or series on the last trading day of the specified trading period in which such security was listed or quoted on the highest trading marketplace

11.53 $______________________ (iii)

Number of securities in the class or series of such security outstanding at the end of the last trading day of the specified trading period

14,267,174 ________________________ (iv)

Market value of class or series

(iii) x (iv)

164,500,516.22 $________________________ (B)

3rd Specified Trading Period (dd/mm/yy) (refer to the definition of “specified trading period” under OSC Rule 13-502 Fees)

01/07/15 30/09/15 _________________ to _________________

Closing price of the security in the class or series on the last trading day of the specified trading period in which such security was listed or quoted on the highest trading marketplace

8.26 $ _______________________ (v)

Number of securities in the class or series of such security outstanding at the end of the last trading day of the specified trading period

14,344,267 ________________________ (vi)

Market value of class or series

(v) x (vi)

118,483,645.42 $________________________ (C)

4th Specified Trading Period (dd/mm/yy) (refer to the definition of “specified trading period” under OSC Rule 13-502 Fees)

01/10/15 31/12/15 _________________ to _________________

Closing price of the security in the class or series on the last trading day of the specified trading period in which such security was listed or quoted on the highest trading marketplace

8.04 ________________________ (vii)

Number of securities in the class or series of such security outstanding at the end of the last trading day of the specified trading period

14,385,336 ________________________ (viii)

Market value of class or series

115,658,101.44 (vii) x (viii) $________________________ (D)

5th Specified Trading Period (dd/mm/yy) (if applicable - refer to the definition of “specified trading period” under OSC Rule 13-502 Fees)

_________________ to _________________

Closing price of the security in the class or series on the last trading day of the specified trading period in which such security was listed or quoted on the highest trading marketplace

$_______________________ (ix)

Number of securities in the class or series of such

________________________ (x)

security outstanding at the end of the last trading day of the specified trading period Market value of class or series

(ix) x (x)

$________________________ (E)

Average Market Value of Class or Series (Calculate the simple average of the market value of the class or series of security for each applicable specified trading period (i.e. A through E above))

159,625,232.74 $_________________________ (1)

(Repeat the above calculation for each other class or series of equity securities of the reporting issuer (and a subsidiary pursuant to paragraph 2.8(1)(c) of OSC Rule 13-502 Fees, if applicable) that was listed or quoted on a marketplace at the end of the previous financial year) Fair value of outstanding debt securities: (See paragraph 2.8(1)(b), and if applicable, paragraph 2.8(1)(c) of OSC Rule 13-502 Fees)

0 $_________________________ (2)

(Provide details of how value was determined)

Capitalization for the previous financial year

Participation Fee (For Class 1 reporting issuers, from Appendix A of OSC Rule 13-502 Fees, select the participation fee)

(1) + (2)

159,625,232.74 $_________________________

13,340 $_________________________

(For Class 3B reporting issuers, from Appendix A.1 of OSC Rule 13-502 Fees, select the participation fee) Late Fee, if applicable (As determined under section 2.7 of OSC Rule 13502 Fees)

$_________________________

Total Fee Payable (Participation Fee plus Late Fee)

13,340 $_________________________